Learning from History: Making Biosimilars a Reality - Genetic ...
Learning from History: Making Biosimilars a Reality - Genetic ...
Learning from History: Making Biosimilars a Reality - Genetic ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
FDA desire for specific innovations in biotherapeuticanalysisSteven Kozlowski, M.D.Director, Office of Biotechnology ProductsThree Specific Properties Needing Improved MeasurementFDA has identified three properties of therapeutic proteins that cannot besufficiently measured at this time but that are very important for understandingthe behavior of protein drugs. Improved analytical methods to measure these threeproperties would be particularly useful in determining the extent of similarity ofbiological protein products intended to be similar.1. Post-translation Modifications …2. Three-dimensional Structure …3. Protein Aggregation …TESTIMONY BEFORE THESUBCOMMITTEE ON TECHNOLOGY AND INNOVATIONCOMMITTEE ON SCIENCE AND TECHNOLOGYU.S. HOUSE OF REPRESENTATIVESSEPTEMBER 24, 2009